Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endometrial Neoplasms × Tiragolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Head and Neck Neoplasms 3 Neoplasms 2 Melanoma 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Solid Tumor, Adult 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Advanced Solid Malignancies 1

Interventions

Paclitaxel 35 Carboplatin 28 pembrolizumab 22 Surveys and Questionnaires 20 Letrozole 14 Radiotherapy 13 Bevacizumab 13 Blood Specimen Collection 12 Metformin 11 Megestrol Acetate 11 olaparib 10 dostarlimab 10 Observation 9 Medroxyprogesterone Acetate 9 Indocyanine Green 9 Cisplatin 9 durvalumab 8 lenvatinib 7 Sentinel Lymph Node Biopsy 7 Radiation 7 Magnetic Resonance Spectroscopy 7 Lymph Node Excision 7 Early Intervention, Educational 7 atezolizumab 6 abemaciclib 6 Taxes 6 Specimen Handling 6 Methods 6 Hysterectomy 6 Everolimus 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2025-09-04

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡